sFlt-1 is the soluble form of the VEGF receptor (VEGFR1), released in low levels during normal pregnancy and significantly upregulated in preeclampsia where it binds and neutralizes pro-angiogenic molecules VEGF and PlGF in the circulation36. This evidence concerns the gene FLT1 and preeclampsia.